Seelos Therapeutics
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001136261-21-000021
- Document
- 8-K
- Exhibit 99.1
- Press release
- Signs a material agreement (1.01)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
